Valeant Pharmaceuticals SWOT Analysis, Competitors & USP

Published by MBA Skool Team, Last Updated: April 12, 2020

SWOT analysis of Valeant Pharmaceuticals analyses the brand by its strengths, weaknesses, opportunities & threats. In Valeant Pharmaceuticals SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like Valeant Pharmaceuticals to benchmark its business & performance as compared to the competitors. Valeant Pharmaceuticals is one of the leading brands in the pharma and healthcare sector.

The table below lists the Valeant Pharmaceuticals SWOT (Strengths, Weaknesses, Opportunities, Threats), top Valeant Pharmaceuticals competitors and includes its target market, segmentation, positioning & Unique Selling Proposition (USP).

Valeant Pharmaceuticals SWOT Analysis, Competitors, Segmentation, Target Market, Positioning, USP & Brand Analysis Table
Valeant Pharmaceuticals Brand Analysis
Parent Company

Valeant Pharmaceuticals International




Pharma and Healthcare

Tagline/ Slogan

Multinational specialty pharmaceutical company


It  is leading company in neurology & dermatology segments

Valeant Pharmaceuticals STP

Dermatology, neurology & ophthalmic segment

Target Group

Healthcare professionals, patients & hospitals operating in these segments


It is diversifies specialty pharmaceutical company

SWOT Analysis of Valeant Pharmaceuticals
Valeant Pharmaceuticals Strengths

Below are the Strengths in the SWOT Analysis of Valeant Pharmaceuticals:

1. It has over 7500 employees in the organization

2. It has broad product base with over  900 products

3. It has strong product pipeline with many molecules in last stages of development

4. Their recent acquisitions have further strengthened their presence in generic market
5. Specialization in neurology and dermatology
6. Manufacturing sites in Canada, Brazil, Poland and Mexico

Valeant Pharmaceuticals Weaknesses

Here are the weaknesses in the Valeant Pharmaceuticals SWOT Analysis:

1. Company has limited presence in emerging markets which has huge potential

2. Largely dependent upon America for revenue generation

Valeant Pharmaceuticals Opportunities

Following are the Opportunities in Valeant Pharmaceuticals SWOT Analysis:

1. Opportunity to grow in new markets such as Russia & Brazil through acquisitions

2. Strong growth in generics & OTC drugs

3. Increasing ageing populations

Valeant Pharmaceuticals Threats

The threats in the SWOT Analysis of Valeant Pharmaceuticals are as mentioned:

1. US healthcare reforms

2. Economic slowdown reducing spend on healthcare

3. Strong competition in branded drugs segments

Valeant Pharmaceuticals Competition
Valeant Pharmaceuticals Competitors

Below are the top 4 competitors of Valeant Pharmaceuticals:

1. Forest labs
2. Allergan

3. Roche pharmaceuticals

4. Novartis

This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Valeant Pharmaceuticals. This section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2500 brands from over 20 industry sectors.

Continue Reading:

The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute

Share this Page on:
Facebook ShareTweetShare on Linkedin